Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1019 | 954 | 1019 | 1078 | 1458 | 2253 |
Fund Return | 1.9% | -4.63% | 1.9% | 2.55% | 7.83% | 8.46% |
Place in category | 453 | 533 | 453 | 89 | 52 | 109 |
% in Category | 48 | 55 | 48 | 12 | 10 | 35 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA Framlington Global Technology a | 1.31B | 20.02 | 4.23 | 18.77 | ||
AXA Framlington Global Technology F | 1.31B | 20.03 | 4.23 | 18.77 | ||
GB00B5LXGG05 | 1.22B | 26.53 | 9.40 | 16.67 | ||
AXA Global Distribution Fund Z GBPa | 276.22M | 6.54 | -0.51 | 5.75 | ||
AXA Global Distribution Fund Z GBPi | 276.22M | 6.56 | -0.52 | 5.83 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 4.02B | 5.16 | 5.09 | 10.55 | ||
Wellington Global Health Care EquiG | 2.07B | 6.70 | 4.03 | 11.14 | ||
Adamant Medtech I GBP | 1.68B | 10.76 | 0.98 | 12.16 | ||
Global Health Care Fund W Acc GBP | 113.3M | 1.25 | -0.40 | 8.83 | ||
Pharmaceuticals Index Trust F Acc | 272.59K | 3.03 | 1.86 | 9.24 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.58 | 811.08 | -1.48% | |
UnitedHealth | US91324P1021 | 6.29 | 542.49 | -0.56% | |
Novo Nordisk B | DK0062498333 | 5.94 | 607.3 | +0.60% | |
Merck&Co | US58933Y1055 | 5.17 | 98.82 | -0.13% | |
AstraZeneca | GB0009895292 | 4.31 | 11,344.0 | +0.27% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review